SCHEMBL28678702

SCHEMBL28678702

C=CCSC(OC(=O)O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.45
CYP2D6 P10635 2/20 0.38
CYP1A2 P05177 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP3A4 P08684 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SRC P12931 1/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
OPRD1 P41143 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6125635 0.76 CYP2C19 (0.51) CYP2C19CYP2D6PKMSMN1; SMN2SLC6A3
SCHEMBL1458053 0.76 CYP2C19 (0.51) CYP2C19CYP2D6PKMSMN1; SMN2SLC6A3
SCHEMBL1458049 0.76 CYP2C19 (0.51) CYP2C19CYP2D6PKMSMN1; SMN2SLC6A3
SCHEMBL10584727 0.73 EPHX1 (0.54) CYP2C19CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL11032151 0.72 CYP2C19 (0.56) CYP2C19CYP2D6CYP1A2PKMSMN1; SMN2
Lithium Ion SCHEMBL1457968 0.72 CYP2C19 (0.44) CYP2C19CYP2D6CYP1A2PKMSMN1; SMN2
Lithium Ion SCHEMBL1458160 0.72 CYP2C19 (0.44) CYP2C19CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL1758751 0.71 CYP2C19 (0.40) CYP2C19CYP2D6CYP1A2SMN1; SMN2CYP3A4
SCHEMBL5955000 0.69 TSHR (0.31) TSHR
SCHEMBL2886387 0.69 CYP2C19 (0.43) CYP2C19CYP2D6CYP3A4HCAR2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174281-A Degradation agent for cyclin dependent kinase 7(CDK7) and use thereof 达纳-法伯癌症研究公司 2022-03-11 CN disclosed
CN-113993519-A Degradation agent for cyclin dependent kinase 12(CDK12) and use thereof 达纳-法伯癌症研究公司 2022-01-28 CN disclosed